The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.
Year: 1992
Type: article
Study design: Observational Study
Source: PubMed
Institution: University of North Carolina at Chapel Hill
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2270763952
